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Abstract
Background: Traumatic brain injury (TBI) is an important cause of acquired disability. In evaluating
the effectiveness of clinical interventions for TBI it is important to measure disability accurately.
The Glasgow Outcome Scale (GOS) is the most widely used outcome measure in randomised
controlled trials (RCTs) in TBI patients. However GOS measurement is generally collected at 6
months after discharge when loss to follow up could have occurred. The objectives of this study
were to evaluate the association and predictive validity between a simple disability scale at hospital
discharge, the Oxford Handicap Scale (OHS), and the GOS at 6 months among TBI patients.
Methods: The study was a secondary analysis of a randomised clinical trial among TBI patients
(MRC CRASH Trial). A Spearman correlation was estimated to evaluate the association between
the OHS and GOS. The validity of different dichotomies of the OHS for predicting GOS at 6
months was assessed by calculating sensitivity, specificity and the C statistic. Uni and multivariate
logistic regression models were fitted including OHS as explanatory variable. For each model we
analysed its discrimination and calibration.
Results: We found that the OHS is highly correlated with GOS at 6 months (spearman correlation
0.75) with evidence of a linear relationship between the two scales. The OHS dichotomy that
separates patients with severe dependency or death showed the greatest discrimination (C
statistic: 84.3). Among survivors at hospital discharge the OHS showed a very good discrimination
(C statistic 0.78) and excellent calibration when used to predict GOS outcome at 6 months.
Conclusion: We have shown that the OHS, a simple disability scale available at hospital discharge
can predict disability accurately, according to the GOS, at 6 months. OHS could be used to improve
the design and analysis of clinical trials in TBI patients and may also provide a valuable clinical tool
for physicians to improve communication with patients and relatives when assessing a patient's
prognosis at hospital discharge.
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Background
Traumatic brain injury (TBI) is an important cause of
acquired disability. In evaluating the effectiveness of clin-
ical interventions for TBI it is important to measure disa-
bility accurately. The Glasgow Outcome Scale (GOS) is
the most widely used outcome measure in randomised
controlled trials (RCTs) in TBI patients.[1] However,
because the GOS assesses how well patients function in
their daily social interactions, it is only applicable after the
patient has been discharged from hospital.
Loss to follow up after hospital discharge is a common
problem in clinical trials in TBI and some amount of miss-
ing data is often unavoidable.[2] If an early outcome
measure was available that could predict long term disa-
bility, it could be valuable for dealing with missing data,
and might potentially be used as a surrogate outcome.
The MRC CRASH Trial was a large, randomised placebo
controlled trial of the effects of a 48-hour infusion of cor-
ticosteroids on death and disability, among 10,008
adults.[3] Using data from this cohort of patients we have
previously identified hospital admission variables that
accurately predict 6 months GOS.[4] This cohort also
presents an opportunity to evaluate the predictive validity
of an early disability outcome measure for TBI patients. A
modified version of the Oxford Handicap Scale (OHS)
was completed at hospital discharge and the GOS was
completed at 6 months after injury. The OHS, which was
originally developed for stroke patients, comprises six cat-
egories: no symptoms, minor symptoms, minor handi-
cap, moderate handicap, moderately severe handicap, and
severe handicap.[5] In the MRC CRASH Trial a modified
form of the OHS was used in which moderate handicap
and moderately severe handicap were combined.
Although the OHS has been previously used in brain
injury trials, its association with GOS at 6 months in TBI
patients has not been previously reported.[5]
The aim of this paper is to describe the association
between an early disability outcome (OHS), and a 6
months disability outcome (GOS). Specifically the objec-
tives were to:
1) Evaluate the correlation between OHS at hospital dis-
charge and GOS at 6 months
2) Evaluate different dichotomies of the OHS at hospital
discharge in predicting GOS at 6 months
3) Evaluate the extent to which OHS at hospital discharge
predicts GOS at 6 months in survivors
Methods
Potential predictor
The OHS (table 1) was assessed at 14 days, hospital dis-
charge or death (whichever occur first).
Variables that have previously been reported to be associ-
ated with the outcome were considered as potential con-
founders and included in an adjusted model: age,
Glasgow Coma Scale (GCS) at randomization, pupil reac-
tivity, whether the patient sustained a major extra cranial
injury and computerised tomography (CT) scan
results.[4]
Table 1: Original Oxford Handicap Scale and OHS used in the MRC CRASH Trial
Original OHS Modified OHS used in CRASH
Categories Categories
No symptoms No symptoms
Minor symptoms that do not interfere with lifestyle Minor symptoms
Minor handicap, symptoms that lead to some restriction in lifestyle but do not interfere with 
the patient's capacity to look after himself
Some restriction in lifestyle but independent
Moderate handicap, symptoms that significantly restrict lifestyle and prevent totally independent 
existence
Dependent but not requiring constant attention
Moderately severe handicap, symptoms that clearly prevent independent existence though not 
needing constant attention
Severe handicap, totally dependent patient requiring constant attention night and day Fully dependent requiring attention day and night
DeathBMC Medical Research Methodology 2008, 8:72 http://www.biomedcentral.com/1471-2288/8/72
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Outcome
The outcome was GOS at 6 months. The GOS comprises
five categories: death, persistent vegetative state, severe
disability, moderate disability and good recovery.[6] GOS
was dichotomised for analysis in the CRASH Trial into
favourable outcome (good recovery or moderate disabil-
ity) and unfavourable outcome (severe disability, persist-
ent vegetative state or death). We created two further
dichotomies: good recovery versus other outcomes, and
survival versus death.
The sample of patients
The MRC CRASH trial was a large international double-
blind randomised placebo-controlled trial of the effect of
early administration of a 48-h infusion of a corticosteroid
(methylprednisolone) on the risk of death and disability
after TBI. The characteristics of the patients randomised,
and results of the trial have already been reported in
detail.[3,7] Briefly, adults (aged 16 years or older) with a
head injury and a GCS of 14 or less were randomly allo-
cated to commence either a 48 hour infusion of methyl-
prednisolone or matching placebo within eight hours of
injury; patients from 239 hospitals in 48 countries were
randomised. All collaborating MRC CRASH investigators
were required to secure local ethics or research committee
approval before recruitment could begin. Patients with
clinically significant head injury are unable to give valid
informed consent. Local ethics committees set consent
procedures for participating hospitals. Some allowed con-
sent waiver and others consent from a legal representative.
We always adhered to these requirements.
Of 10,008 study participants enrolled in the MRC CRASH
Trial, 99 (1%) had missing data on the OHS, 418 (4.2%)
had missing data on the GOS at 6 months, and 36 (0.3%)
had missing data for both OHS and GOS. A further 8
patients were excluded from analysis as they had a Glas-
gow Coma Scale (GCS) score of 15 at randomisation.
Analysis for objectives 1 and 2 were therefore performed
using data for 9,447 (94.4%) patients (figure 1). For the
third objective (predictive validity of OHS among survi-
vors), the 1,948 patients who died within 14 days of
admission were excluded and the analysis was based on
data for the remaining 7,499 patients (figure 1).
Analysis
Objective 1
A cross-tabulation between the OHS and GOS categories
was performed. Their relation was assessed with the Spear-
man rank correlation index.
Objective 2
The validity of the different dichotomies of the OHS for
predicting GOS at 6 months was assessed by calculating
sensitivity, specificity and the c statistic (an equivalent
concept to area under the receiver operator characteristic
curve).
Flowchart of patients used in the analysis Figure 1
Flowchart of patients used in the analysis.
10,008     Enrolled in trial 
    99 no data on OHS at 14 days 
  418 no data on GOS at 6 months 
  36 no data on both OHS and GOS 
  8 not TBI (GCS 15) 
9,447 (94.4%)    Sample for objectives 1 and 2 
      1,948  died at 14 days 
7,499 (74.9%)    Sample for objective 3 BMC Medical Research Methodology 2008, 8:72 http://www.biomedcentral.com/1471-2288/8/72
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Objective 3
A logistic regression model was first fitted including only
OHS as explanatory variables (model 1). A second model
was then fitted that also included demographic and clini-
cal variables (model 2). Finally, a third model was fitted
that included all variables in model 2, plus CT scan varia-
bles. All the demographic, clinical and CT variables have
been previously reported as being independently associ-
ated with unfavourable outcome at 6 months.[4] For each
model we analysed its discrimination using the c statistic
and calibration (graphically and with the Hosmer-Leme-
show test).
We then estimated the positive predictive value (with 95%
confidence intervals) of each OHS category for GOS at 6
months.
Results
General characteristics of the population
Table 2 shows the characteristics of the sample included in
the analysis. At 14 days 1,863 (19%) were dependent and
1,948 patients had died (21%). At 6 months, 3,525
(37.3%) patients were severely disabled or had died. Most
deaths (84%) occurred within the first 14 days. OHS at 14
days and GOS at 6 months were highly correlated (Spear-
man rank correlation coefficient 0.75) and they showed a
linear relationship (figure 2).
OHS for predicting 6 months outcome
Five dichotomies of the OHS were considered (Table 3).
When their validity was assessed in relation to unfavoura-
ble outcome as defined by the GOS (severe disability or
death), dichotomy D showed the highest discrimination
(c statistic) with high specificity (Table 4).
Among survivors at hospital discharge the OHS showed a
strong association with GOS at 6 months. The crude anal-
ysis showed that patients who were fully dependent at 14
days had 24 higher odds of an unfavourable outcome at 6
months. Although adjusting for known prognostic factors
attenuated the strength of the association, OHS remained
a strong predictor with a highly statistically significant test
(Table 5). Most importantly, when considered alone,
Relationship between Oxford Handicap Scale and unfavourable outcome (GOS) at 6 months Figure 2
Relationship between Oxford Handicap Scale and unfavourable outcome (GOS) at 6 months.BMC Medical Research Methodology 2008, 8:72 http://www.biomedcentral.com/1471-2288/8/72
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OHS showed very good discrimination and excellent cali-
bration (H-L = 1) (figure 3).
Table 6 shows the prediction of different 6 months out-
comes (as measured with GOS) according to the hospital
discharge OHS. For example, a patient with minor symp-
toms at hospital discharge will have a probability of
approximately 67% of good recovery, 89% of good recov-
ery or moderate disability and 98% of survival at 6
months.
Discussion
Principal findings
We found that the OHS is highly correlated with GOS at 6
months with evidence of a linear relationship between the
two scales. The OHS dichotomy that separate patients
who were severely dependent or dead (dichotomy D)
showed the greatest discrimination. Among survivors at
hospital discharge the OHS showed a very good discrimi-
nation and excellent calibration when used to predict
GOS outcome at 6 months.
Strengths and weakness of the study
To our knowledge this is the first study that evaluated the
predictive validity of a simple scale for disability at hospi-
tal discharge in TBI patients. The main strengths of our
study include the large sample size which ensures preci-
sion in our estimates, and the inclusion of patients from
both high and low & middle income countries, which
increases the generalizability of our conclusions. The
main limitation is that the measurement of OHS was not
standardized between centres. However, because we
would expect that any measurement error would result in
non-differential misclassification, in general we would
expect that the association reported would be underesti-
mated rather than overestimated. Finally, our study is the
Table 2: Glasgow Outcome Scale at 6 months by Oxford Handicap Scale at 14 days
Glasgow Outcome Scale at 6 months
Oxford Handicap Scale at 14 days Good recovery Moderate disability Severe disability Death Total
n% n%n% n%n
No symptoms 1,910 79 334 14 150 6 17 1 2411
Minor symptoms 1,646 67 537 22 233 9 42 2 2,458
Some restriction in lifestyle but independent 354 46 246 32 147 19 20 3 767
Dependent but not requiring constant attention 232 30 273 35 221 29 45 6 771
Fully dependent requiring attention day & night 148 14 242 22 457 42 245 22 1,092
Death 0 0 0 0 0 0 1948 100 1948
Total 4,290 45 1,632 17 1,208 13 2317 25 9,477
Table 3: Dichotomies of OHS for determining unfavourable outcome
ABCDE
No Symptoms No No No No No
Minor Symptoms Yes No No No No
Some restriction in lifestyle but independent Yes Yes No No No
Dependent but not requiring constant attention Yes Yes Yes No No
Fully dependent requiring attention day and night Yes Yes Yes Yes No
Death Yes Yes Yes Yes YesBMC Medical Research Methodology 2008, 8:72 http://www.biomedcentral.com/1471-2288/8/72
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first to report this association which should therefore be
examined in an external cohort of patients in order to con-
firm the findings.
Comparison with other studies
The incidence of unfavourable GOS outcome at 6 months
in our cohort was lower in comparison to one reported in
a series of TBI cohorts.[8] However, unlike ours, most of
these cohorts had been restricted to severe TBI patients.
The OHS has previously been used in RCTs of brain injury
patients, and Bamford et al. reported good inter-observer
agreement (a weighted kappa of 0.72).[5] Ours is the first
study in TBI which has evaluated the relationship between
OHS and GOS. Nevertheless, previous studies have shown
a good agreement between the Modified Rankin Scale (the
scale from which the OHS was derived) and the GOS.[9]
Conclusion
We have shown that OHS is strongly related and predicts
accurately the GOS at 6 months. It may therefore be help-
ful in tackling the problem of missing data in clinical trials
in TBI. It might also serve as a potential surrogate outcome
measure and this application should be explored in fur-
ther studies. If our findings are replicated, OHS could be
a simple and useful outcome measure to use in trials in
settings for which long term follow-up is problematic.
Furthermore, OHS could be a useful variable to collect in
rehabilitation trials in TBI patients to ensure that there is
a similar distribution of disability among participants
Table 5: Association between OHS and unfavourable outcome (GOS) among survivors
Model 1 Model 2 Model 3
95% CI 95% CI 95% CI
OHS OR Lower Upper OR Lower Upper OR Lower Upper
1.0 1.0
Minor symptoms 1.7 1.4 2.1 1.6 1.3 1.9 1.6 1.3 2.0
Some restriction in lifestyle but independent 3.7 3.0 4.7 2.7 2.1 3.4 2.7 2.1 3.5
Dependent but not requiring constant attention 7.1 5.7 8.8 4.5 3.6 5.7 4.7 3.7 6.0
Fully dependent requiring attention day & night 24.1 19.8 29.4 12.9 10.3 16.2 13.3 10.4 16.9
C statistic for the model 0.78 0.83 0.83
Model 1: OHS
Model 2: model 1 plus GCS, pupil reactivity, major extra-cranial injury and age
Model 3: model 2 plus CT findings (petechial haemorrhages, obliteration of the third ventricle or basal cisterns, subarachnoid bleed, midline shift, 
non evacuated haematoma)
Table 4: Validity of the Oxford Handicap Scale at 14 days for 
Glasgow Outcome Scale at 6 months
OHS dichotomy Sensitivity Sensitivity C stat
A 95.3 37.9 66.6
B 87.5 74.8 81.1
C 82.7 84.9 83.8
D 75.2 93.4 84.3
E 55.3 100.0 77.6
Calibration of model 1 Figure 3
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between groups at baseline. We have also shown that,
among survivors, the OHS is able to predict disability at 6
months and thus may provide a valuable clinical tool for
physicians to improve communication with patients and
relatives when assessing a patient's prognosis at hospital
discharge.
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Table 6: Prediction of three dichotomies of GOS at 6 months according to OHS
Good recovery Good recovery or Moderate disability Survival
95% CI 95% CI 95% CI
OHS % Lower Upper % Lower Upper % Lower Upper
No symptoms 79.2 77.6 80.8 93.1 92.1 94.1 99.3 99.0 99.6
Minor symptoms 67.0 65.1 68.8 88.8 87.6 90.1 98.3 97.8 98.8
Some restriction in lifestyle but independent 46.1 42.6 49.7 78.2 75.3 81.2 97.4 96.3 98.6
Dependent but not requiring constant attention 30.1 26.8 33.3 65.5 62.1 68.9 94.2 92.5 95.8
Fully dependent requiring attention day & night 13.6 11.5 15.6 35.8 32.9 38.6 77.6 75.1 80.0